The novelty of our finding is that the CD8+ cytotoxic T cell density can be used as a single marker of good prognosis, independently of tumor compartment, i.e., core or invasive margin, in non-metastatic stage CRC. This evidence concerns the gene CD8A and colorectal carcinoma.